Ionis Pharmaceuticals reported $-102.29M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Arrowhead Research USD -141.26M 182.07M Mar/2026
Astellas Pharma JPY 185.36B 136.79B Jun/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
BioMarin Pharmaceutical USD 129.65M 68.74M Mar/2026
Celltrion KRW 13.41B 1.33B Mar/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 820.88M 192.13M Sep/2023
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Exelixis USD 251.34M 15.43M Mar/2026
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Kangmei Pharma CNY -12.72M 13.97M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -36K 12.96M Dec/2025
Moderna USD -815M 573M Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Neurocrine Biosciences USD 219.9M 5.3M Jun/2026
Novartis USD 4.73B 549M Jun/2026
Omeros USD -48.15M 7.25M Sep/2023
OPKO Health USD -50.02M 11.7M Mar/2026
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pfizer USD -180M 5.16B Jun/2026
Pharma Mar EUR -1.4M 2.03M Jun/2026
PTC Therapeutics USD 45.89M 127.51M Mar/2026
Qiagen NV USD 96.88M 25M Mar/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sarepta Therapeutics USD 358.43M 768.52M Mar/2026
Sartorius EUR 164M 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026
Zealand Pharma A/S -389M 318.05M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026